Hello and welcome to Regulator, an email for Verge subscribers about technology, politics, and what happens when science crashes headlong into self-interest. Not a subscriber? Sign up here today! Got the scoop on a petty feud that's going to somehow fundamentally reshape the entire field of frontier AI development? Send 'em over to tina.nguyen+tips@theverge.com.

Back when I was covering Donald Trump's first presidency, it was incredibly common to read three different versions of the same story. His administration had split into several factions, all of which had different interests, and all of which hated each other. There was the Reince Pr …

Read the full story at The Verge.

In a groundbreaking advancement that bridges the gap between biological intelligence and artificial systems, researchers at Oregon State University have engineered a light-sensitive device that not only detects visual stimuli but also bio-mimics the brain’s ability to store and modulate memories dynamically. Drawing direct inspiration from the complex workings of human neural processes, this pioneering approach integrates sensing, memory, and signal processing into a single phototransistor, a feat poised to revolutionize the future of neuromorphic computing.

Traditional artificial intelligence hardware architectures typically bifurcate these essential functions—detection, memory retention, and processing—forcing data to shuttle between distinct components. This separation not only introduces latency but significantly amplifies energy consumption. The novel phototransistor developed by the OSU team disrupts this paradigm by embedding memory capabilities precisely where sensory inputs occur, vastly improving computational efficiency and speed.

Central to this device’s innovation is its ability to mimic the neurochemical processes governing memory strength and decay in the human brain. Rather than storing information with fixed permanence, the phototransistor utilizes trapped electrical charges generated by incident light to represent memories, which can then be pharmacologically tuned—via electrical gate voltages—to either reinforce or weaken these stored traces over time. This dynamic modulation reproduces the adaptive nature of biological synapses and opens unprecedented avenues for creating AI systems that can ‘forget’ as well as ‘remember,’ essential for real-time learning and adaptation.

Structurally, the device marries an oxide semiconductor acting as the electronic transistor channel with an organic photosensitive layer responsible for absorbing photons and generating charge carriers. The organic layer traps a subset of these carriers, creating a persistent local electric field even after illumination ceases. This trapped charge influences electron flow through the semiconductor channel, effectively encoding a memory of prior light exposure.

A key technical breakthrough lies in the device’s gate-tunable interface: by adjusting the voltage applied to the transistor’s gate terminal, researchers can manipulate the spatial positioning of trapped charges relative to the conduction channel at a nanoscopic level. This precise control modulates the strength of electrical interaction, allowing for programmable decay times of the optoelectronic memory—ranging from seconds to considerably longer durations. Such flexibility is vital for neuromorphic systems requiring adjustable time constants for processing temporal patterns.

The implications of this technology extend beyond simple visual sensing. By localizing both sensing and adaptive memory functions, the phototransistor can serve as a foundational building block for advanced vision systems capable of real-time data processing with exceptional energy efficiency. This novel hardware approach offers substantial improvements over conventional sensors, which often offload processing to centralized units, incurring latency and energy penalties.

Neuromorphic computing, a field striving to emulate the architecture and operational principles of the brain, stands to gain significantly from this development. The device’s capacity to embody synapse-like plasticity within a phototransistor embodies a leap toward systems that do not merely compute but adapt, learn, and optimize autonomously. Furthermore, the integration of these functionalities at the hardware level paves the way for compact, scalable AI platforms potentially transformative for robotics, autonomous vehicles, and sensory-rich IoT devices.

The research team acknowledges that the trapped charges’ mobility within the device’s photosensitive layer marks a fundamental departure from fixed-charge memory devices. By enabling charge repositioning in response to externally applied voltages, the phototransistor achieves an unprecedented degree of control over memory retention timescales—a property rarely realized in optoelectronic components designed for AI applications.

From an energy perspective, co-localizing sensing and computation reduces data transfer bottlenecks traditionally plaguing AI processors. This attribute directly addresses pressing challenges in AI hardware, where escalating computational demands often collide with limitations in battery life and thermal management. As a result, the novel phototransistor aligns with broader efforts to develop sustainable, high-performance AI technologies.

Conceived through a multidisciplinary collaboration spanning electrical engineering and physical sciences at Oregon State University, the device’s development also underscores the growing convergence of materials science with computational intelligence. By synergizing metal oxide semiconductors with organic tetracene compounds, the team harnessed complementary material properties—robust electron transport with efficient light absorption—to realize the device’s multifunctional capabilities.

The National Science Foundation’s support, alongside the efforts of researchers including Larry Cheng, Ahasan Ullah, Tasnim Sarker, Xueqiao Zhang, Andrew Ensinger, Lizhong Chen, Roshell Lamug, and Oksana Ostroverkhova, culminated in the publication of their findings in the esteemed journal Advanced Functional Materials. The study not only charts new territory in optoelectronics but also sets the stage for transformative innovation in neuromorphic computing hardware.

As artificial intelligence increasingly demands systems capable of real-world adaptability and resource efficiency, innovations like this gate-tunable neuro-phototransistor epitomize the direction forward. By drawing directly from the brain’s principles of memory modulation and energy-efficient computation, the OSU team’s technology heralds a new era where AI devices can perceive, process, and remember in ways that approximate human cognition more closely than ever before.

Subject of Research: Not applicable

Article Title: Neuromodulator-Inspired Gate-Tunable Tetracene–Metal Oxide Phototransistor for Adaptive Optoelectronic Memory and Neuromorphic Computing

News Publication Date: 19-May-2026

Web References: http://dx.doi.org/10.1002/adfm.75942

References: Published in Advanced Functional Materials

Image Credits: Oregon State University

Keywords

Neuromorphic computing, phototransistor, adaptive memory, optoelectronics, brain-inspired AI, gate-tunable memory, oxide semiconductor, organic photosensitive material, energy-efficient AI, in-sensor computing, tetracene, neuromodulation

A groundbreaking study originating from the Canadian Institute for Substance Use Research (CISUR) at the University of Victoria has fortified the growing scientific consensus that links alcohol consumption to the onset of pancreatic cancer. This research not only enriches our understanding of alcohol’s carcinogenic risks but specifically addresses a critical gap in epidemiological studies by controlling for a pervasive methodological bias that has long obscured clear causative associations.

Pancreatic cancer remains one of the most fatal malignancies, notorious for its late detection and subsequent poor prognosis. Current statistics reveal that only about 12 percent of diagnosed individuals in Canada survive beyond five years, underscoring the urgency of clarifying preventable risk factors. The importance of linking alcohol consumption explicitly to this disease cannot be overstated, as it potentially opens avenues for impactful public health interventions aimed at reducing incidence and mortality rates.

The study, recently published in the International Journal of Alcohol and Drug Research, employed a painstakingly rigorous meta-analysis and systematic review of cohort studies—longitudinal observational research that monitors large populations over extended periods to capture disease development in relation to lifestyle factors. This analytical approach allowed the researchers to consolidate disparate findings and enhance the precision of risk estimates associated with alcohol intake.

A pivotal aspect of this investigation was the mitigation of the “former drinker” bias. Traditionally, epidemiological studies have classified individuals who abstain from drinking to encompass those who either never consumed alcohol or ceased consumption at some prior time. This conflation can skew results because individuals who quit drinking might do so due to deteriorating health, possibly from alcohol-related illnesses, thus inflating risk metrics among abstainers and confounding the true relationship between current drinking habits and cancer risk.

Dr. Jinhui Zhao, the lead scientist of the study, elaborates on the significance of differentiating between lifelong abstainers and former drinkers, explaining that failure to do so can mask the genuine deleterious impacts of alcohol. By isolating the former drinker population in their analysis, the research team effectively purified the data, allowing a more accurate dose-response curve to emerge between alcohol consumption and the development of pancreatic cancer.

After meticulous adjustment for confounding variables such as age, smoking status, and socioeconomic factors, the researchers unveiled a robust dose-dependent correlation. Specifically, consuming more than 24 grams of alcohol daily—equivalent to slightly less than two standard Canadian drinks—was associated with a 10 to 30 percent heightened risk of developing pancreatic cancer. This finding is particularly compelling as it delineates a clear quantitative threshold of alcohol consumption that markedly increases carcinogenic risk.

Tim Naimi, CISUR’s director and co-author, emphasizes the transformative implications of these results by advocating for the inclusion of pancreatic cancer within the cadre of recognized alcohol-related cancers. Currently, the World Health Organization acknowledges seven cancer types linked to alcohol, such as those affecting the mouth, breast, and colon. The addition of pancreatic cancer would significantly sharpen public health messaging and potentially influence guidelines for alcohol consumption worldwide.

Methodologically, the study underscores the necessity of employing refined epidemiological techniques to counteract biases that have historically hampered clarity in addiction-related cancer research. The researchers’ comprehensive approach, combining cohort data with stringent bias control, sets a new standard for future investigations into lifestyle factors influencing cancer risks.

The implications of this research extend beyond academic circles, bearing profound consequences for clinical practice and prevention strategies. Health professionals can leverage this evidence to counsel patients more effectively on the carcinogenic risks posed by alcohol, particularly in populations already vulnerable to pancreatic pathology. Furthermore, these findings might catalyze regulatory bodies to reassess and tighten alcohol consumption recommendations.

This investigation corroborates the growing volume of experimental and observational data identifying ethanol and its metabolic byproducts as carcinogens capable of inducing genetic mutations, inflammatory pathways, and cellular disruptions within pancreatic tissue. The dose-response relationship elucidated by the team mirrors mechanistic insights gleaned from molecular biology studies, further validating the causal link between alcohol and cancer genesis.

In a public health context, the study’s results highlight the urgency of integrating alcohol risk awareness into cancer prevention frameworks. Educational campaigns, policy interventions, and healthcare guidelines must adapt to encompass this expanded risk profile, ensuring that individuals receive accurate information about alcohol’s potential to contribute to deadly diseases beyond those currently recognized.

While this meta-analysis marks a significant advance, the authors acknowledge the continuing need for longitudinal research with granular consumption data and biomarker validation to deepen our comprehension of alcohol’s multifaceted role in pancreatic carcinogenesis. Nonetheless, this study establishes a crucial evidentiary foundation advocating for heightened vigilance and proactive measures against alcohol-related pancreatic cancer risks.

For readers seeking an in-depth examination, the full paper titled “Alcohol consumption and the risk of pancreatic cancer: A systematic review and meta-analysis of cohort studies,” is accessible in the International Journal of Alcohol and Drug Research and represents a seminal contribution to the field.

Subject of Research: Alcohol consumption and its relationship with pancreatic cancer risk
Article Title: Alcohol consumption and the risk of pancreatic cancer: A systematic review and meta-analysis of cohort studies
Web References: https://ijadr.org/index.php/ijadr/article/view/649, http://dx.doi.org/10.7895/ijadr.649
Keywords: Alcohol abuse, pancreatic cancer, epidemiology, dose-response, cohort studies, former drinker bias, carcinogenesis, public health, risk factors

In a significant advancement that reshapes our understanding of alcohol’s carcinogenic profile, researchers at the University of Victoria’s Canadian Institute for Substance Use Research (CISUR) have provided compelling evidence linking alcohol consumption to pancreatic cancer. This breakthrough, detailed in a recent systematic review and meta-analysis published in the International Journal of Alcohol and Drug Research, underscores a critical public health concern, given pancreatic cancer’s notorious lethality and elusive risk factors.

The global health community, guided by the World Health Organization’s classification, has long acknowledged alcohol as a causal factor in several cancers, including those of the mouth, breast, and colon. However, the relationship between alcohol and pancreatic cancer has been less definitive. The new analysis conducted by CISUR scientists, spearheaded by Tim Naimi and lead author Jinhui Zhao, provides the most rigorous compilation of cohort studies to date, affirmatively adding pancreatic cancer to alcohol’s known carcinogenic portfolio.

Pancreatic cancer remains one of the deadliest malignancies, characterized by late diagnosis and poor survival rates, with merely 12 percent of Canadian patients living beyond five years post-diagnosis. Identifying modifiable risk factors is paramount for prevention efforts, and this study highlights alcohol intake as a significant contributor. Unlike previous epidemiological research susceptible to confounding variables, this meta-analysis painstakingly corrected for former drinker bias—a methodological flaw where individuals who ceased alcohol consumption (often due to health decline) were misclassified as abstainers, skewing risk estimations.

The investigation meticulously sifted through longitudinal cohort data encompassing diverse populations, controlling for age, smoking habits, and socioeconomic status, critical variables that can distort the true association between alcohol and cancer risk. By excluding former drinkers from the abstainer group and focusing on lifelong non-drinkers as the baseline, the researchers eliminated a key source of bias that had previously obscured alcohol’s carcinogenic potential in pancreatic tissue.

A striking dose-response relationship emerged from the data: consumption exceeding 24 grams of ethanol daily, approximately just under two standard drinks in Canada, correlated with a 10 to 30 percent increased risk of pancreatic cancer. This quantitative threshold sharpens public health messaging, providing a concrete benchmark at which alcohol consumption moves from moderate to clinically significant carcinogenic exposure for this specific cancer type.

The biological mechanisms underpinning alcohol-induced pancreatic carcinogenesis are multifaceted. Ethanol metabolism generates acetaldehyde, a potent mutagen that induces DNA damage and promotes malignant transformation. Additionally, chronic alcohol exposure fosters an inflammatory microenvironment within the pancreas, exacerbating fibrosis and cellular stress that facilitate oncogenesis. These pathological alterations compound the pancreas’s vulnerability, illuminating plausible pathways through which alcohol intensifies cancer risk.

Tim Naimi emphasized the imperative for updating global health guidelines to incorporate pancreatic cancer among alcohol-related malignancies, aligning policy with the latest empirical evidence. This paradigm shift mandates enhanced public awareness campaigns and a reevaluation of alcohol consumption advisories, particularly given the high morbidity associated with pancreatic cancer and the preventable nature of toxin exposure.

The study’s robust methodology and comprehensive meta-analytic framework represent a milestone in addiction science and cancer epidemiology, illustrating how careful adjustment for bias and confounders can clarify contentious risk factors. The researchers advocate for ongoing surveillance of alcohol consumption patterns alongside cancer incidence metrics to monitor trends and inform targeted interventions.

Public health stakeholders are urged to recognize the implications of these findings, integrating them into risk reduction strategies that do not merely minimize overall alcohol use but specifically address dosage thresholds linked to increased pancreatic cancer risk. This nuanced understanding equips clinicians and policymakers with evidence-based tools to combat the rising burden of pancreatic malignancies related to lifestyle factors.

In conclusion, this research decisively confirms that alcohol is not only a disruptor of liver and gastrointestinal tract health but is also an independent and modifiable risk factor for pancreatic cancer. The findings encourage a reconsideration of alcohol consumption norms worldwide, advocating for a precautionary approach in both legislative frameworks and individual health decisions.

The CISUR team’s work stands as an exemplar of how epidemiological rigor and critical analysis can refine public health knowledge, ensuring that alcohol-related cancer prevention strategies are both scientifically sound and impactful. As new data emerges, such systemic reviews will be essential in safeguarding health and reducing the global cancer burden attributable to alcohol use.

Subject of Research: Alcohol consumption and its causative link to pancreatic cancer

Article Title: Alcohol consumption and the risk of pancreatic cancer: A systematic review and meta-analysis of cohort studies.

Web References:
https://ijadr.org/index.php/ijadr/article/view/649
http://dx.doi.org/10.7895/ijadr.649

Keywords: Alcohol abuse, pancreatic cancer, alcohol-related cancer, epidemiology, cohort studies, dose-response relationship, carcinogenesis, acetaldehyde, inflammation, former drinker bias, public health, cancer prevention